Abstract
Background
Asthma in elderly patients causes excessive suffering and inconvenience. Regimens with better efficacy and less adverse events are still in need of researches.
Aims
To investigate the effect of montelukast sodium plus budesonide on lung function, inflammatory factors, and immune levels in elderly asthma patients.
Methods
A total of 180 patients with asthma were assigned into the control group and the observation group. The control group was given aerosol inhalation of budesonide suspension, while the observation group was given budesonide inhalation and oral montelukast sodium. The treatment effect, lung function (forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF)%), inflammatory factors (interleukin (IL)-4, IL-6, and tumor necrosis factor-α (TNF-α)), and immune level (immunoglobulin (Ig) A, and IgE) were analyzed and compared between the two groups.
Results
After treatment, the effective rate was significantly higher in the observation group. The lung function and serum inflammatory factors were improved in both groups. The FEV1, FVC, and PEF% in the observation group were better, and the inflammatory factors IL-4, IL-6, and TNF-α were lower. Patients in both groups showed elevated IgA level and reduced IgE level, and the improvements were more significant in the observation group. There was no significant difference between the two groups in terms of adverse reaction.
Conclusions
Montelukast sodium plus budesonide has a promising clinical effect on asthma in elderly patients, effectively improves lung function and immunocompetence, and controls inflammatory response, without increasing the adverse reaction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nieto-Fontarigo JJ, Gonzalez-Barcala FJ, San Jose E et al (2019) CD26 and asthma: a comprehensive review. Clin Rev Allergy Immunol 56(2):139–160. https://doi.org/10.1007/s12016-016-8578-z
Ciprandi G, Schiavetti I, Ricciardolo FLM (2018) The impact of aging on outpatients with asthma in a real-world setting. Respir Med 136:58–64. https://doi.org/10.1016/j.rmed.2018.01.018
Dunn RM, Busse PJ, Wechsler ME (2018) Asthma in the elderly and late-onset adult asthma. Allergy 73(2):284–294. https://doi.org/10.1111/all.13258
Lee SH, Song WJ, Park HW, Kang MG, Kim SH, Park HK, Kim SH, Kwon YE, Kim TB, Lee BJ, Jee YK, Choi BW, Cho SH, Kim SS (2018) Multifaceted interventions to reduce acute exacerbations in elderly asthmatics. Asia Pac Allergy 8(1):e1. https://doi.org/10.5415/apallergy.2018.8.e1
McKeever T, Mortimer K, Wilson A, Walker S, Brightling C, Skeggs A, Pavord I, Price D, Duley L, Thomas M, Bradshaw L, Higgins B, Haydock R, Mitchell E, Devereux G, Harrison T (2018) Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations. N Engl J Med 378(10):902–910. https://doi.org/10.1056/NEJMoa1714257
He Y, Shi J, Nguyen QT, You E, Liu H, Ren X, Wu Z, Li J, Qiu W, Khoo SK, Yang T, Yi W, Sun F, Xi Z, Huang X, Melcher K, Min B, Xu HE (2019) Development of highly potent glucocorticoids for steroid-resistant severe asthma. Proc Natl Acad Sci U S A 116(14):6932–6937. https://doi.org/10.1073/pnas.1816734116
Fang S, Song Y, Zhang S, Li C (2019) Retrospective study of budesonide in children with eosinophilic gastroenteritis. Pediatr Res 86(4):505–509. https://doi.org/10.1038/s41390-019-0444-2
Lavakumar V, Sowmya C, Venkateshan N et al (2018) Microcapsule based chronomodulated drug delivery systems of montelukast sodium in the treatment of nocturnal asthma. Int J Pharm Investig 8(1):24–32
Mo LH, Zhong L (2017). Clinical observation of montelukast combined with budesonide in the treatment of bronchial asthma in children. China Pharmacy
Zhao HS, Li HF (2018) The observation of curative effect on leukotriene receptor antagonist combined with inhaled hormone in the treatment of moderately severe asthma. Journal of Kunming Medical University
Boulet L (2017). Pathophysiology of asthma. Applied Respiratory Pathophysiology. CRC Press 67-96
Yu QN, Guo YB, Li X, Li CL, Tan WP, Fan XL, Qin ZL, Chen D, Wen WP, Zheng SG, Fu QL (2018) ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma. Allergy 73(9):1860–1870. https://doi.org/10.1111/all.13438
Pelaia G, Vatrella A, Busceti MT, Fabiano F, Terracciano R, Matera MG, Maselli R (2016) Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma. Pulm Pharmacol Ther 40:15–21. https://doi.org/10.1016/j.pupt.2016.07.001
Lu W, Lu C, Zhang C, Zhang C (2017) One mechanism of glucocorticoid action in asthma may involve the inhibition of IL-25 expression. Exp Ther Med 13(2):657–661. https://doi.org/10.3892/etm.2016.4002
Shao H, Cheng B, Zhao J et al (2016) Influence of different doses budesonide aerosol inhalation on serum cytokines levels in children with severe asthma. Chin J Primary Med Pharm 23(7):1083–1086
Al-Nemer OA, Alshareef HJ, Aljehani AA et al (2017) A review of the pathogenesis of pediatric asthma and the effect of leukotriene modifiers in pediatric asthma management. Egyptian Journal of Hospital Medicine 69(5)
Liu M, Yokomizo T (2015) The role of leukotrienes in allergic diseases. Allergol Int 64(1):17–26. https://doi.org/10.1016/j.alit.2014.09.001
Song DB, Pediatrics DO (2017) Effect of montelukast sodium chewable tablet in the treatment of children with bronchial asthma. Journal of Xinxiang Medical University
Luo S, Emergency DO (2015) Curative effect of albuterol sulfate aerosol inhalation and theophylline tablets among elderly patients with acute asthma. Journal of Bethune Medical Science 5:479–480
Hui C, Hongfei L, Yang W et al (2018) Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis. International Forum of Allergy & Rhinology 8(11):1242–1252
Chen Q (2018) Efficacy of oral montelukast combined with budesonide suspension inhalation in the treatment of children with cough variant asthma and its effect on inflammatory cytokines. Chin J Primary Med Pharm 25(2):244–248
Li JM, Li QL (2015) Dynamic changes in serum immunoglobulin E and T lymphocytes in children with bronchial asthma. Journal of Hainan Medical University 21(3):313–315
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. And this study was approved by the Ethics Committee of Zhangye People’s Hospital Affiliated to Hexi University.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, Y., Li, B. Effects of montelukast sodium plus budesonide on lung function, inflammatory factors, and immune levels in elderly patients with asthma. Ir J Med Sci 189, 985–990 (2020). https://doi.org/10.1007/s11845-019-02167-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-019-02167-5